Galati, Salvatore

Helicobacter pylori eradication and l-dopa absorption in patients with PD and motor fluctuations

Pierantozzi, M., Pietroiusti, A., Brusa, L., Galati, S., Stefani, A., Lunardi, G., Fedele, E., Sancesario, G., Bernardi, G., Bergamaschi, A., et al. (2006) · Neurology

Parkinson's Disease Mechanisms and TreatmentsHelicobacter pylori-related gastroenterology studies

Cited by 199

CSF biomarkers, impairment of cerebral hemodynamics and degree of cognitive decline in Alzheimer's and mixed dementia

Stefani, A., Sancesario, G., Pierantozzi, M., Leone, G., Galati, S., Hainsworth, A. H., & Diomedi, M. (2009) · Journal of the Neurological Sciences

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 80

Autonomic Function Tests and MIBG in Parkinson's Disease: Correlation to Disease Duration and Motor Symptoms

Rocchi, C., Pierantozzi, M., Galati, S., Chiaravalloti, A., Pisani, V., Prosperetti, C., Lauretti, B., Stampanoni Bassi, M., Olivola, E., Schillaci, O., et al. (2015) · CNS Neuroscience & Therapeutics

Parkinson's Disease Mechanisms and TreatmentsCardiovascular Syncope and Autonomic Disorders

Cited by 31

Sleep-wake cycle and effects of cabergoline monotherapy in de novo Parkinson’s disease patients: An ambulatory polysomnographic study

Placidi, F., Izzi, F., Romigi, A., Stanzione, P., Marciani, M. G., Brusa, L., Sperli, F., Galati, S., Pasqualetti, P., & Pierantozzi, M. (2008) · Journal of Neurology

Parkinson's Disease Mechanisms and TreatmentsSleep and related disorders

Cited by 21

Cerebrospinal-fluid Alzheimer’s Disease Biomarkers and Blood-Brain Barrier Integrity in a Natural Population of Cognitive Intact Parkinson’s Disease Patients

Liguori, C., Olivola, E., Pierantozzi, M., Cerroni, R., Galati, S., Saviozzi, V., Mercuri, N. B., & Stefani, A. (2017) · CNS & Neurological Disorders - Drug Targets

Parkinson's Disease Mechanisms and TreatmentsDementia and Cognitive Impairment Research

Cited by 20